DALLAS MEDICAL CENTER — History
CCN 450379 | 3-year financial timeline | COVID resilience: 17/100
🛡️ Public data only — no PHI permitted on this instance.
$34M
Latest Revenue (FY2022)
-13.0%
Revenue CAGR (3yr)
-55.5%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $45M | $40M | $34M | -14.9% | -13.0% |
| Operating Expenses | $59M | $55M | $53M | -4.3% | -4.9% |
| Operating Margin | -30.2% | -38.3% | -55.5% | -45.0% | +0.0% |
| Net Income | $-14M | $-15M | $-19M | -23.3% | +0.0% |
| Licensed Beds | 119 | 119 | 119 | +0.0% | +0.0% |
| Total Patient Days | 9,154 | 8,224 | 6,246 | -24.1% | -17.4% |
| Medicare Day % | 26% | 22% | 27% | +24.2% | +3.1% |
| Medicaid Day % | 4% | 3% | 1% | -63.5% | -49.2% |
COVID Impact & Recovery
Resilience Score: 17/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -24.3% ($45M → $34M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
-13.0%
This Hospital
+7.6%
State Avg
Latest Margin
-55.5%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $29M | -68.1% |
| FY2024 (proj) | $23M | -80.7% |
| FY2025 (proj) | $18M | -93.4% |